About 8 Trademarks found for “BTG”

Pharmaceutical preparations and substances for the treatment of cancer, cardiovascular diseases, thrombosis, embolisms, inflammation, varicose veins, envenomation by snakes, digoxin, digitalis and other cardioactive glycoside toxicity, methotrexate toxicity, human vaccines and blood and immune serum; pharmaceutical preparations and substances for use in the circulatory system for the treatment of cardiovascular diseases, thrombosis, embolisms, varicose veins, envenomation by snakes, digoxin, digitalis and other cardio-active glycoside toxicity and methotrexate toxicity; pharmaceutical preparations and substances for embolisation; pharmaceutical preparations and substances for embolisation of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemicopharmaceutical preparations for the treatment of envenomation by snakes; chemical preparations for medical or pharmaceutical purposes for the treatment of envenomation by snakes; medicines for the treatment of envenomation by snakes; pharmaceutical preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical preparations for the treatment of pre-eclampsia; chemical reagents for medical therapeutic and diagnostic purposes, namely, for the treatment of cancer, cardiovascular diseases, thrombosis, embolisms, inflammation, varicose veins, autoimmune disease, envenomation by snakes, digoxin, digitalis and other cardio-active glycoside toxicity, methotrexate toxicity, chemicopharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia; chemical preparations for medical or pharmaceutical purposes and medicines for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; transarterial chemoembolisation pharmaceutical preparations, vaccines and sera; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances, namely, radioactive glass beads, for medical purposes; radiopharmaceuticals; therapeutic agents for delivery of radioactive material to target sites within the body; embolising beads, namely, microscopic radioactive beads, for treatment of cancerous tumours; embolising beads, namely, microscopic glass beads, impregnated with radioactive material for treatment of cancerous tumours; radioactive glass beads for the treatment of tumours; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and medically activate drugs; pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams or for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; pharmaceutical preparations containing methotrexate antidotes; pharmaceutical preparations containing 5-fluorouracil antidotes; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations used for regulating toxicity levels of therapeutic agents; pharmaceutical preparations used for depleting concentrations of therapeutic agents.

Drug delivery embolisation apparatus, instruments and systems comprising catheters and injection syringes; drug delivery apparatus comprising injection syringes and microspheres for use in blood vessels and the circulatory system to carry out embolisation; surgical and medical apparatus and instruments for embolisation, namely, drug delivery chemoembolisation instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolisation; drug delivery apparatus, namely, an embolic drug eluting bead capable of loading and releasing chemotherapeutic agents in a controlled manner used in trans-arterial chemoembolisation; drug delivery apparatus and instruments comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical instruments for embolisation; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy equipment used to deliver radioactive beads; radiotherapy equipment used to deliver radiopharmaceuticals and radioactive material to target sites within the body; beads, namely, microscopic glass beads, impregnated with radioactive material or containing radioactive material and administered surgically for treatment of cancerous tumours; radioactive beads, namely, radioactive glass beads administered for treatment of cancerous tumours; medical devices which use ultrasound to enhance drug delivery and medically activate drugs, namely, catheters and control units for catheters; catheters for delivery of drugs or fluids and controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus and controllers, namely, catheters and control units for catheters and power units therefor; needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus, namely, catheters, canisters and foam generators for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus, namely, catheters, canisters and foam generators for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical or medical apparatus, namely, catheters, canisters and foam generators for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; syringes for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; surgical and medical apparatus, namely, catheters, canisters and foam generators for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus, namely, catheters, canisters and foam generators for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hycroceles; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; devices, namely ultrasound scanners for assessing the physical characteristics of such foams; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical devices namely ultrasound scanners for monitoring the position and effect of foam in the human body; medical diagnostic apparatus, namely ultrasound machines, for use in sclerotherapy, phlebology, angiology and proctology, for the treatment of oesophageal varices, hydroceles, in sterilisation treatment and for treatment of varicose veins, and arterio-venous malformations, and for the treatment of cancer.

Pre-recorded CDs, computer chips and memory sticks containing information in the pharmaceutical, surgical, medical, medical diagnostic, biotechnology, drug discovery or healthcare fields; computer firmware for controlling medical devices; computer firmware for controlling and managing patient medical information; computer hardware; computer peripherals; computer software for use in ultrasound devices; computer software for use in medical devices, namely, software for the operation of medical devices and for analyzing the results of testing completed through medical devices; computer software for use in ultrasound devices, namely, software for the operation of ultrasound devices and for analyzing ultrasound images; computer software for medical monitoring, medical testing and patient evaluating programs; computer software for the diagnosis, treatment, and management of health conditions and illnesses; computer software for the diagnosis, assessment, treatment, management, and aftercare of conditions in the fields of sclerotherapy, phlebology, angiology, proctology and interventional oncology and emphysema; computer software for the diagnosis, assessment, treatment, management, and aftercare of tumors; computer software for the diagnosis, assessment, treatment, management, and aftercare of varicose veins, arterio-venous malformations, oesophageal varices, and hydroceles; computer software for the diagnosis, assessment, treatment, management and aftercare of emphysema; computer software for controlling and managing patient medical information; computer programs for controlling and managing patient medical information; computer programs for use in the field of health care for the collection, maintenance and management of data for patient records, clinical diagnosis and assessment, patient treatment, goals management, outcome analysis, scheduling, health care facilities management, materials management, resources utilization, billing and accounting, and the review of health care facilities, services and clinical records; computer software for use by health care providers to analyze the outcomes of medical procedures and information relating to patient care; computer software for use in database management; computer database software for clinical use, clinical governance, clinical audit, collecting and analyzing information relating to patient demographics, procedures and outcomes; downloadable software in the nature of a mobile application for handheld computers, mobile computer devices, mobile phones, media players, that provides access to information, advice and calculation tools in the fields of healthcare, medicine, medical treatment and patient care; computer software for controlling and managing patient medical information; computer programs for controlling and managing patient medical information; computer database software for clinical use, clinical governance, clinical audit, collecting and analyzing information relating to patient demographics, procedures and outcomes; computer software for use in monitoring and diagnosing biochemical reactions and phenomena; computer programs for use in the field of healthcare for the collection, maintenance and management of data for patient records, clinical diagnosis and assessment, patient treatment, goals management, outcome analysis, scheduling, healthcare facilities management, materials management, resources utilization, billing and accounting, and the review of healthcare facilities, services and clinical records; computer software for use by healthcare providers to analyse the outcomes of medical procedures and information relating to patient care; computer software for use in database management, namely, computer databases for clinical use, clinical governance, clinical audit, collecting and analysing information relating to patient demographics, procedures and outcomes; electronic questionnaires; electronic patient reported outcome questionnaires; electronic patient reported outcome questionnaires for use with a telecommunications device; downloadable publications in electronic form, namely, instruction leaflets, manuals, newsletters, questionnaires, journals, magazines, periodicals, articles and books in the pharmaceutical, surgical, medical, medical diagnostic, biotechnology, drug discovery or healthcare fields; downloadable electronic publications provided on-line from databases or the internet, namely, instruction leaflets, manuals, newsletters, questionnaires, journals, magazines, periodicals, articles and books in the pharmaceutical, surgical, medical, medical diagnostic, biotechnology, drug discovery or healthcare fields; downloadable publications in electronic form supplied on-line from databases or from facilities provided on the internet (including websites), namely, instruction leaflets, manuals, newsletters, questionnaires, journals, magazines, periodicals, articles and books in the pharmaceutical, surgical, medical, medical diagnostic, biotechnology, drug discovery, or healthcare fields; electrically operated diagnostic testing apparatus and instruments, namely, electrically operated diagnostic testing apparatus and instruments for use in the fields of sclerotheraphy, phlebology, angiology proctology, interventional oncology, tumors, basal cell carcinoma, emphysema, varicose veins, arterio-venous malformations, oesophageal varices, hydroceles; ultrasonic medical diagnostic apparatus.

Printed matter and printed publications, namely, instruction leaflets, manuals, newsletters, questionnaires, journals, magazines, periodicals, articles, books, manuals, brochures and other literature in the pharmaceutical, surgical, medical, medical diagnostic, biotechnology, drug discovery or healthcare fields; printed journals, printed periodicals, printed reports and printed questionnaires in the field of healthcare, pharmaceutical products, healthcare and medical diseases, disorders and related treatments, medicine, medical treatment and related hot line services, patient care, prescription drugs, ordering, prescribing, and dispensing practices of drugs, treatment and aftercare guidelines; wallet cards and documents providing personal and/or medical information concerning an individual's health condition; wallet cards and documents providing contact information for a medical information hotline.

Chemicals for use in the pharmaceutical industry, chemicals for use in scientific and medical research; diagnostic preparations and reagents for in vitro use, pharmaceutical and medicinal preparations and substances, namely, vaccines and vaccine adjuvants, proteins, peptides, sera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating snake envenomation, overdose of toxic substances and sepsis; preparations for the neutralisation and absorption of toxic and overdosed substances; veterinary pharmaceutical preparations for the treatment of digoxin, digitalis and other cardio-active glycoside activity; pharmaceutical preparations for the prevention of viral and bacterial disease, namely, human vaccines and vaccine adjuvants; blood serums; chemical reagents for diagnostic purposes, namely chemical reagents for in vivo use; polyclonal antibodies and fragments thereof for in vitro disease testing and for use in treating snake envenomation, overdose of toxic substances and sepsis, therapeutic antibodies for use as anti-lymphocytic agents; pharmaceutical preparations in the form of foams and for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment and for treatment of varicose veins, and arterio-venous malformations; chemical reagents for medical research use, veterinary medicine, and for therapy and medical diagnostics; pharmaceutical preparations for the treatment of cancer; pharmaceutical and veterinary preparations for the reduction and elimination of circulating cytokines; pharmaceutical preparations for the treatment of methotrexate toxicity; pharmaceutical preparations for the treatment of cancer namely prostate, oesophageal and brain cancer and leukaemias; pharmaceutical preparations for the treatment of sepsis; surgical instruments, medical instruments for general examination; hypodermic syringes, medical tubing; surgical and medical apparatus, namely, syringes, hypodermic needles, subdermal auto-injectors, gas-liquid mixing units for producing therapeutic foams, mechanical pumps for producing and administering foams for the treatment of varicose veins, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus, namely, syringes, hypodermic needles, subdermal auto-injectors, gas-liquid mixing units for producing therapeutic foams, mechanical pumps for producing and administering sclerosing foams; surgical and medical apparatus namely, syringes, gas-liquid mixing units for producing therapeutic foams, mechanical pumps for producing foam sclerosant drugs for use in sclerotherapy, phlebology, angiology and proctology, sterilisation treatment and for treatment of varicose veins, arterio-venous malformations, oesophageal varicoses and hydroceles; surgical and medical devices, namely ultrasound machines for assessing the physical characteristics of foam sclerosant drugs, medical devices for intravenous administration of foam sclerosant drugs, namely syringes, gas-liquid mixing units for producing therapeutic foams, hypodermic needles, subdermal auto-injectors and mechanical, medical devices for monitoring the position and effect of foam sclerosant drugs in the human body, namely ultrasound machines; medical diagnostic devices, namely ultrasound machines, for use in sclerotherapy, phlebology, angiology and proctology, for the treatment of oesophageal varices, hydroceles, in sterilisation treatment and for treatment of varicose veins, and arterio-venous malformations, for the treatment of cancer, the reduction of elimination of circulating cytokines, methotrexate toxicity, the treatment of cancer namely prostate, oesophageal and brain cancer and leukaemias and the treatment of sepsis; haemofiltration devices, namely medical instruments used for blood filtration.

Pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis and other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for treatment of envenomation by snakes; artificial limbs, orthopaedic articles, namely knee and hip joint replacement parts.

Surgical and medical apparatus, devices and instruments; surgical and medical apparatus, devices and instruments for use in the prevention and treatment of circulatory system issues and conditions; surgical and medical apparatus, devices and instruments for use in the prevention and treatment of pulmonary embolisms, thrombus, blood clots, vascular issues and conditions; bio-absorbable medical apparatus, devices and instruments; bio-absorbable medical apparatus, devices and instruments for use in the vascular system; medical and surgical filters; vena cava filters; vascular filters; introducers for implanting vena cava filters; medical and surgical catheters; intravenous catheters; parts and fittings for all the aforesaid goods.

Education services, namely, developing, arranging and conducting educational programmes and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, blood clots, vascular issues and conditions, and distribution of course material in connection therewith; training in the use and operation of medical devices and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions, and training programs in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, blood clots, vascular issues and conditions, and distribution of course material in connection therewith; educational services, namely, providing non-downloadable webinars in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, blood clots, vascular issues and conditions, and distribution of course material in connection therewith; provision of educational content, namely, providing on-line instruction in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, blood clots, vascular issues and conditions, and distribution of course material in connection therewith; providing information about medical education in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care via computer, electronic and on-line databases; advisory services in the field of medical education; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions and training in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; educational services, namely, providing non-downloadable webinars in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and distribution of course material in connection therewith; non-downloadable electronic publications in the nature of teaching guides, instructional materials, brochures, and course books in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, blood clots, vascular issues and conditions; providing educational information via electronic online databases featuring information about medical education in the field of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine.

Pharmaceutical preparations and substances for the treatment of cancer, cardiovascular diseases, thrombosis, embolisms, inflammation, varicose veins, envenomation by snakes, digoxin, digitalis and other cardioactive glycoside toxicity, methotrexate toxicity; human vaccines and blood and immune serum; pharmaceutical preparations and substances for use in the circulatory system for the treatment of cardiovascular diseases, thrombosis, embolisms, varicose veins, envenomation by snakes, digoxin, digitalis and other cardio-active glycoside toxicity and methotrexate toxicity; pharmaceutical preparations and substances for embolisation; pharmaceutical preparations and substances for embolisation of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemicopharmaceutical preparations for the treatment of envenomation by snakes; chemical preparations for medical or pharmaceutical purposes for the treatment of envenomation by snakes; medicines for the treatment of envenomation by snakes; pharmaceutical preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical preparations for the treatment of pre-eclampsia; chemical reagents for medical therapeutic and diagnostic purposes, namely, for the treatment of cancer, cardiovascular diseases, thrombosis, embolisms, inflammation, varicose veins, autoimmune disease, envenomation by snakes, digoxin, digitalis and other cardio-active glycoside toxicity, methotrexate toxicity; chemicopharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia; chemical preparations for medical or pharmaceutical purposes and medicines for use in the treatment of digoxin, digitalis or other cardio active glycoside toxicity and for use in the treatment of preeclampsia; transarterial chemoembolisation pharmaceutical preparations, vaccines and sera; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances, namely, radioactive glass beads, for medical purposes; radiopharmaceuticals; therapeutic agents for delivery of radioactive material to target sites within the body; embolising beads, namely, microscopic radioactive beads, for treatment of cancerous tumours; embolising beads, namely, microscopic glass beads, impregnated with radioactive material for treatment of cancerous tumours; radioactive glass beads for the treatment of tumours; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and medically activate drugs; pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams or for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; pharmaceutical preparations containing methotrexate antidotes; pharmaceutical preparations containing 5-fluorouracil antidotes; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations used for regulating toxicity levels of therapeutic agents; pharmaceutical preparations used for depleting concentrations of therapeutic agents.

Drug delivery embolisation apparatus, instruments and systems comprising catheters and injection syringes; drug delivery apparatus comprising injection syringes and microspheres for use in blood vessels and the circulatory system to carry out embolisation; surgical and medical apparatus and instruments for embolisation, namely, drug delivery chemoembolisation instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolisation; drug delivery apparatus, namely, an embolic drug eluting bead capable of loading and releasing chemotherapeutic agents in a controlled manner used in trans-arterial chemoembolisation; drug delivery apparatus and instruments comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical instruments for embolisation; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolization; radiotherapy equipment used to deliver radioactive beads; radiotherapy equipment used to deliver radiopharmaceuticals and radioactive material to target sites within the body; beads, namely, microscopic glass beads, impregnated with radioactive material or containing radioactive material and administered surgically for treatment of cancerous tumours; radioactive beads, namely, radioactive glass beads administered for treatment of cancerous tumours; medical devices which use ultrasound to enhance drug delivery and medically activate drugs, namely, catheters and control units for catheters; catheters for delivery of drugs or fluids and controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus and controllers, namely, catheters and control units for catheters and power units therefor; needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus, namely, catheters, canisters and foam generators for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus, namely, catheters, canisters and foam generators for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical or medical apparatus, namely, catheters, canisters and foam generators for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; syringes for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; surgical and medical apparatus, namely, catheters, canisters and foam generators for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus, namely, catheters, canisters and foam generators for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; devices, namely ultrasound scanners for assessing the physical characteristics of such foams; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical devices namely ultrasound scanners for monitoring the position and effect of foam in the human body; medical diagnostic apparatus, namely ultrasound machines, for use in sclerotherapy, phlebology, angiology and proctology, for the treatment of oesophageal varices, hydroceles, in sterilisation treatment and for treatment of varicose veins, and arterio-venous malformations, and for the treatment of cancer.

Pre-recorded CDs, computer chips and memory sticks containing information in the pharmaceutical, surgical, medical, medical diagnostic, biotechnology, drug discovery or healthcare fields; computer firmware for controlling medical devices; computer firmware for controlling and managing patient medical information; computer hardware; computer peripherals; computer software for use in ultrasound devices; computer software for use in medical devices, namely, software for the operation of medical devices and for analyzing the results of testing completed through medical devices; computer software for use in ultrasound devices, namely, software for the operation of ultrasound devices and for analyzing ultrasound images; computer software for medical monitoring, medical testing and patient evaluating programs; computer software for the diagnosis, treatment, and management of health conditions and illnesses; computer software for the diagnosis, assessment, treatment, management, and aftercare of conditions in the fields of sclerotherapy, phlebology, angiology, proctology and interventional oncology and emphysema; computer software for the diagnosis, assessment, treatment, management, and aftercare of tumors; computer software for the diagnosis, assessment, treatment, management, and aftercare of varicose veins, arterio-venous malformations, oesophageal varices, and hydroceles; computer software for the diagnosis, assessment, treatment, management and aftercare of emphysema; computer software for controlling and managing patient medical information; computer programs for controlling and managing patient medical information; computer programs for use in the field of health care for the collection, maintenance and management of data for patient records, clinical diagnosis and assessment, patient treatment, goals management, outcome analysis, scheduling, health care facilities management, materials management, resources utilization, billing and accounting, and the review of health care facilities, services and clinical records; computer software for use by health care providers to analyze the outcomes of medical procedures and information relating to patient care; computer software for use in database management; computer database software for clinical use, clinical governance, clinical audit, collecting and analyzing information relating to patient demographics, procedures and outcomes; downloadable software in the nature of a mobile application for handheld computers, mobile computer devices, mobile phones, media players, that provides access to information, advice and calculation tools in the fields of healthcare, medicine, medical treatment and patient care; computer software for controlling and managing patient medical information; computer programs for controlling and managing patient medical information; computer database software for clinical use, clinical governance, clinical audit, collecting and analyzing information relating to patient demographics, procedures and outcomes; computer software for use in monitoring and diagnosing biochemical reactions and phenomena; computer programs for use in the field of healthcare for the collection, maintenance and management of data for patient records, clinical diagnosis and assessment, patient treatment, goals management, outcome analysis, scheduling, healthcare facilities management, materials management, resources utilization, billing and accounting, and the review of healthcare facilities, services and clinical records; computer software for use by healthcare providers to analyse the outcomes of medical procedures and information relating to patient care; computer software for use in database management, namely, computer databases for clinical use, clinical governance, clinical audit, collecting and analysing information relating to patient demographics, procedures and outcomes; electronic questionnaires; electronic patient reported outcome questionnaires; electronic patient reported outcome questionnaires for use with a telecommunications device; downloadable publications in electronic form, namely, instruction leaflets, manuals, newsletters, questionnaires, journals, magazines, periodicals, articles and books in the pharmaceutical, surgical, medical, medical diagnostic, biotechnology, drug discovery or healthcare fields; downloadable electronic publications provided on-line from databases or the internet, namely, instruction leaflets, manuals, newsletters, questionnaires, journals, magazines, periodicals, articles and books in the pharmaceutical, surgical, medical, medical diagnostic, biotechnology, drug discovery or healthcare fields; downloadable publications in electronic form supplied on-line from databases or from facilities provided on the internet (including websites), namely, instruction leaflets, manuals, newsletters, questionnaires, journals, magazines, periodicals, articles and books in the pharmaceutical, surgical, medical, medical diagnostic, biotechnology, drug discovery, or healthcare fields; electrically operated diagnostic testing apparatus and instruments, namely, electrically operated diagnostic testing apparatus and instruments for use in the fields of sclerotheraphy, phlebology, angiology proctology, interventional oncology, tumors, basal cell carcinoma, emphysema, varicose veins, arterio-venous malformations, oesophageal varices, hydroceles; ultrasonic medical diagnostic apparatus.

Printed matter and printed publications, namely, instruction leaflets, manuals, newsletters, questionnaires, journals, magazines, periodicals, articles, books, manuals, brochures and other literature in the pharmaceutical, surgical, medical, medical diagnostic, biotechnology, drug discovery or healthcare fields; printed journals, printed periodicals, printed reports and printed questionnaires in the field of healthcare, pharmaceutical products, healthcare and medical diseases, disorders and related treatments, medicine, medical treatment and related hot line services, patient care, prescription drugs, ordering, prescribing, and dispensing practices of drugs, treatment and aftercare guidelines; wallet cards and documents providing personal and/or medical information concerning an individual's health condition; wallet cards and documents providing contact information for a medical information hotline.

Chemicals for use in the pharmaceutical industry, chemicals for use in scientific and medical research; diagnostic preparations and reagents for in vitro use, pharmaceutical and medicinal preparations and substances, namely, vaccines and vaccine adjuvants, proteins, peptides, sera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating snake envenomation, overdose of toxic substances and sepsis; pharmaceutical preparations and substances for the treatment of thrombosis, inflammation, preparations for the neutralisation and absorption of toxic and overdosed substances; veterinary pharmaceutical preparations for the treatment of digoxin, digitalis and other cardio-active glycoside activity; cosmetics and skin preparations for medical purposes, namely, preparations for treatment of varicose veins; immunization in the form of human and veterinary vaccines; blood serums; diagnostic preparations and reagents for in vivo use for medical purposes; polyclonal antibodies and fragments thereof for in vitro disease testing and for use in treating snake envenomation, overdose of toxic substances and sepsis, therapeutic antibodies for use as anti-lymphocytic agents; pharmaceutical preparations in the form of foams and for use in producing foams for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment and for treatment of varicose veins, and arterio-venous malformations; pharmaceutical preparations in the form of foams and for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment and for treatment of varicose veins, and arterio-venous malformations; chemical reagents for medical research use, veterinary medicine, and for therapy and medical diagnostics; pharmaceutical preparations for the treatment of cancer; pharmaceutical and veterinary preparations for the reduction and elimination of circulating cytokines; pharmaceutical preparations for the treatment of methotrexate toxicity; pharmaceutical preparations for the treatment of cancer namely prostate, oesophageal and brain cancer and leukaemias; surgical instruments, medical instruments for general examination, hypodermic syringes, medical tubing; surgical and medical generators and instruments for producing and administering foams for treatment of varicose veins, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical generators and instruments for producing and administering sclerosing foams; surgical and medical generators and instruments for producing foamed sclerosant drugs for use in sclerotherapy, phlebology, angiology and proctology, sterilisation treatment and for treatment of varicose veins, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical generators and instruments for assessing the physical characteristics of foamed sclerosant drugs, medical generators and instruments for intravenous administration of foamed sclerosant drugs, medical instruments for monitoring the position and effect of foamed sclerosant drugs in the human body; medical diagnostic generators and instruments for use in sclerotherapy, phlebology, angiology and proctology, for the treatment of oesophageal varices, hydroceles, in sterilisation treatment and for treatment of varicose veins, and arterio-venous malformations, for the treatment of cancer, the reduction of elimination of circulating cytokines, methotrexate toxicity, the treatment of cancer namely prostate, oesophageal and brain cancer and leukaemias; haemofiltration instruments used for blood conservation; haemofiltration instruments, namely medical instruments used for blood filtration.

Pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for treatment of envenomation by snakes; artificial limbs, orthopaedic articles, namely knee and hip joint replacement parts.